<collection><source>PMC</source><date>20201214</date><key>pmc.key</key><document><id>29068</id><infon key="license">NO-CC CODE</infon><passage><infon key="article-id_doi">10.1186/1471-2121-2-3</infon><infon key="article-id_pmc">29068</infon><infon key="article-id_pmid">11231877</infon><infon key="article-id_publisher-id">1471-2121-2-3</infon><infon key="fpage">3</infon><infon key="journal-title">BMC Cell Biology</infon><infon key="lpage">3</infon><infon key="name_0">surname:Gruber;given-names:Helen E</infon><infon key="name_1">surname:Puzanov;given-names:Igor J</infon><infon key="name_2">surname:Bennett;given-names:Michael</infon><infon key="name_3">surname:Kumar;given-names:Vinay</infon><infon key="name_4">surname:Gordon;given-names:Brian</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">2</infon><infon key="year">2001</infon><offset>0</offset><text>Alterations in osteoclast morphology following long-term 17beta-estradiol administration in the mouse</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>102</offset><text>What is the background on this?</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>113</offset><text>Despite the increasing understanding of the role of osteoclast in bone resorption, there is still not enough information available about osteoclastogenesis or the mechanism of action of anti-resorbing agents such as 17-estradiol. This study examined the effects of estrogen exposure on bone and morphologic osteoporosis following long-term treatment of B6D2F1 mice.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>754</offset><text>What are the outcomes?</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>762</offset><text>Radiologic examinations after 8 weeks showed severe osteosclerosis, replacing 86% of femoral marrow space with bone. After 12 weeks of treatment, histologic studies revealed that treated animals had tartrate-resistant acid phosphatase in their osteoclasts, but not the required ultrastructure to resorb the bone and prevent successful bone reassemblance.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>1122</offset><text>Remarkable conclusions</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>1134</offset><text>The results provide further insight into the structure and function of osteoclasts in the mouse model undergoing in vivo treatment with high levels of estrogen.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>1426</offset><text>The osteoclast (O1) is a cell-like structure in the bone, which forms the core of the bone marrow. Osteoclast-like structures are produced by osteocytes, which are cells that develop in bone marrow precursor cells. In the case of the O1, the O1 is produced by osteocytes, and it is a primary site for bone marrow differentiation. Osteoclast-like structures can be divided into three types. Type I osteoclast-like structures are associated with bone marrow precursor cells. Type II osteoclast-like structures are associated with bone marrow precursor cells. Type III osteoclast-like structures are associated with bone marrow precursor cells that have not yet differentiated. The O1 is a type III osteoclast-like</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1437</offset><text>While the osteoclast's role in bone resorption is being better understood, there is still not a lot of information about osteoclastogenesis and the specific mechanism of action of anti-resorbing agents on functional osteocrats. 17-estradiol is particularly important because its decline at menopause is linked to the development of postmenopausal osteoporosis.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2023</offset><text>The present report describes alterations in osteoclast morphology following long-term administration of 17-estradiol to B6D2F1 mice. This provides an interesting and useful model as marrow stromal cells, which not only encode the precursors for osteogenic cell lineages but also exert significant effects on osteoclastic and systemic factors.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3115</offset><text>In the current study, osteoclasts were evaluated in mice treated with estrogen to determine if they maintained tartrate-resistant acid phosphatase activity (TRAP) and their normal ultrastructural characteristics.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>3353</offset><text>Results</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>3361</offset><text>Radiographic examination of excised specimens from control and estradiol-treated mice confirmed the presence of osteosclerosis in the femurs of estradiol-treated mice. Diaphyseal cortices were prominent in the midshaft of control specimens (Figure 1A and 1C), but could not be identified in specimens from estradiol-treated animals (Figure 1B, 1D and 1E). These changes were not due to differences in radiographic technique since control and estradiol-treated femurs shown in Figure 1 were exposed side-by-side on the same film.</text></passage><passage><infon key="file">1471-2121-2-3-1.jpg</infon><infon key="id">F1</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>3890</offset><text>Radiographs of femurs from control (A and C) and estradiol-treated (B, D and E) mice. In control femurs (A and C), note that the marrow space and cortical margins are apparent but cannot be seen in specimens from estradiol-treated mice (B, D and E). Femurs marked A and B, and those marked C, D and E were radiographed as a group on the same X-ray film using one exposure to eliminate variability in exposure and development of the films.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>4329</offset><text>Histologic examination also confirmed osteosclerotic features in femurs from estradiol-treated mice. Specimens from estradiol-treated mice contained only small regions of bone marrow (Fig. 2B) in contrast to control bones (Figure 2A). Since the normal, pre-estradiol treatment endosteal margin could still be histologically identified on these specimens, specimens were evaluated with quantitative histomorphometry by first measuring the old, normal marrow area and then measuring the small marrow cavity areas present at time of harvest. On average 86% of mid-shaft marrow space was replaced by bone in estradiol-treated mice at 8 weeks (p &lt; 0.0001 control vs estradiol-treated).</text></passage><passage><infon key="file">1471-2121-2-3-2.jpg</infon><infon key="id">F2</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>5010</offset><text>Photomicrographs of decalcified (A and B) and methacrylate-embedded (C and D) femoral specimens. Cross-sections of normal mice show a normal marrow cavity (Fig. 2A) which is in sharp contrast to the appearance of the cross-section from an estradiol-treated mouse (Fig. 2B) in which only small islands of marrow are present. Localization of Ocl using tartrate-resistant acid phosphatase (TRAP) localization in metaphyseal bone from a normal mouse (Fig. 2C) and from an estradiol-treated mouse (Fig. 2D). (Fig. 2A and 2B, H&amp;E, X 43; Fig. 2C and 2D, TRAP, X 640).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>5571</offset><text>Osteoclasts (Ocl) present in both control and estradiol-treated mice showed positive localization of TRAP (Figure 2C). In contrast to the close apposition of Ocl to the bone surface seen in control specimens, in estradiol-treated animals Ocl extended away from the bone surface with little bone contact (Figure 2D). In order to further investigate this observation, transmission electron microscopy was performed to examine the fine structure of the Ocl in estradiol-treated and control specimens.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>6069</offset><text>Figure 3A illustrates the normal ultrastructural appearance of an Ocl from a control femur; note the normal ruffled border and snug apposition of the Ocl to the bone surface. Ocl from estradiol-treated animals, however, frequently showed only one margin of the cell perimeter involved with small areas of ruffed border formation, with the remainder of the cell surface displaying a smooth profile (Fig. 3B). Some Ocl from estradiol-treated animals had no ruffled borders in spite of the appearance of some attempt to form sealing podosome regions (Fig. 3C).</text></passage><passage><infon key="file">1471-2121-2-3-3.jpg</infon><infon key="id">F3</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>6627</offset><text>Transmission electron micrographs of Ocl from control (Fig. 3A) and from estradiol-treated (Fig. 3B and 3C) mice. Note the normal, extensive ruffled border present on the margin of an Ocl from a control femur (Fig. 3A). In estradiol treated animals, Ocl show either very small portions of the cell perimeter involved with ruffled border formation and the remainder of the cell surface reveals a smooth profile (Fig. 3B) or no ruffled border formation (Fig. 3C). (Fig. 3A, X 3,290; 3B, X 1,310; 3C, X 4,230)</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>7134</offset><text>Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>7145</offset><text>The present study indicated that severe changes in Ocl morphology are associated with the cells' inability to carry out resorption in the osteosclerotic estradiol-treated mouse. Although osteoclasts retained TRAP activity, ultrastructural alterations were identified in estradiol-treated animals in both the sealing patterns of osteoclasts against the bone surface and in altered brush border morphology. Proper sealing of the osteoclast against the bone surface and a functional brush border are two ultrastructural components believed to be of major importance in Ocl function. The ultrastructural alterations identified in estrogen-treated mice were very likely the cellular functional basis for the decreased resorption and development of osteosclerosis in estrogen-treated mice. Osteoclast function and ultrastructural morphology have been shown to be highly responsive to anti-resorbing agents such as ethane-1-hydroxy-1,1-diphosphonate (EHDP), dichloromethylene diphosphanate (Cl2MDP), calcitonin, other anti-resorptive agents, such as mithramycin, and to gallium nitrate.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>8225</offset><text>Although histochemical TRAP localization provides an accurate and sensitive histologic method for identification of Ocl, understanding osteoclastogenesis and Ocl function remain a challenging area of bone research. The current understanding of Ocl function is that the Ocl seals its perimeter along the bone surface by means of the podosome . Within this sealed margin, projections from the cytoplasm form the ruffled border, a specialized Ocl-extracellular space in which bone resorption occurs. In the present study in the mouse, differentiation of osteoclast progenitors appears to be dependent on the direct interaction of bone marrow stromal cells with Ocl precursor cells. Recent data of Baylink and Linkhart provide evidence that two inbred strains of mice with different bone densities may have fundamental differences in bone resorption (not bone formation), and that genes affecting the bone marrow Ocl precursor population may contribute to relative differences in the C57BL/6J and C3H/HeJ strains. In vivo and in vitro studies of avian osteoclasts led Pederson et al to suggest that modulation of the Ocl response to estrogen may be controlled by alterations in the Ocl estrogen receptor level.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>9432</offset><text>Maturation of osteoclasts from their macrophage precursors requires marrow stromal cells or their osteoblast progeny as shown by Udagawa et al. These cells produce macrophage colony-stimulating factor (M-CSF) and the receptor for activation of nuclear factor kappa b (NF-kB) (RANK) ligand (RANKL). M-CSF is essential for macrophage maturation, but formation of osteoclasts also requires contact between osteoclast precursors and stromal cells or osteoblasts. As described by Hofbauer et al, the quantity of bone resorbed depends on the balance between expression of RANKL and of its inhibitor, osteoprotegerin (OPG). Hofbauer et al suggest that the stimulation of the pool of M-CSF precursors to committed osteoclastogenesis by RANKL may be one of the central pathophysiologic pathways involved in increasing the number of osteoclasts in osteoporosis.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>10284</offset><text>Futures studies of the estrogen-treated mouse model are needed which are designed to address osteoclastogenesis and osteoprotegerin (OPG) secretion by osteoblasts. OPG is currently hypothesized to be an important paracrine mediator of the antiresorptive action of estrogen on bone cells. In osteoblast cell lines exposed to estrogen, OPG mRNA and protein levels were increased compared to controls. Hofbauer et al have suggested that estrogen may exert its anti-resorptive effects by enhancement of OPG secretion by osteoblasts.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>10813</offset><text>Future studies should also assess the temporal development of functional changes in the osteoclast populations during estrogen treatment, and the patterns of osteoclast death with special attention to apoptosis. Estradiol has been shown to modulate IL-1 action on human osteoclasts in vitro; estrogen administration inhibited IL-1-mediated cytokine (IL-8) mRNA induction and caused increased Ocl apoptosis. When avian Ocl were exposed to estradiol in vitro, the Ocl plasma membrane became depolarized and there was a marked decrease in potential, suggesting that estrogen may regulate osteoclasts through ion channel activities. Estradiol has also been shown to inhibit acid production in avian Ocl. The human pre-Ocl cell line FLG 29.1 has specific binding sites to 17&#946;-estradiol on the cell surface, and estradiol exposure increases the cellular pH, cAMP, cGMP and intracellular calcium.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>11706</offset><text>In vivo work by Jilka et al has shown that Il-6 can prevent the bone loss associated with ovariectomy in the mouse model. Girasole et al have recently shown that production of IL-6 is inhibited in vitro by exposure of marrow cells to 17&#946;-estradiol; cultures of mouse bone cells showed suppressed osteoclast development when exposed to either 17&#946;-estradiol or a neutralizing antibody to Il-6. Future in vivo studies combining estradiol and selected interleukins may further elucidate how the network of signals from the marrow microenvironment influences both Ocl development and Ocl function.</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_1</infon><offset>12305</offset><text>Remarkable conclusions</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>12317</offset><text>The results provide further insight into the structure and function of osteoclasts in the mouse model undergoing in vivo treatment with high levels of estrogen.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>12609</offset><text>Materials and Methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>12631</offset><text>B6D2F1 mice were selected for this study based upon the following criteria. The C57BL/6 mouse is positive for the NK 1.1 epitope but from previous unpublished data we found that the C57BL/6 responded poorly to estradiol. From previous hybrid resistance studies we had historical data that the B6D2F1 mouse would be positive for the NK 1.1 epitope and respond well to the estradiol. B6D2F1 male mice aged 4-5 weeks were implanted for at least 12 weeks with silastic tubing filled with 15 mg 17&#946;-estradiol; age-matched controls received empty tubing. NK cytolytic functions disappeared in estradiol-treated mice by 8 weeks. Previous work with the model by Roubinian et al showed that administration of 5-6.5 mg estradiol by this method returned estrogen levels to normal in ovariectomized mice for more than 3 months. Seaman et al has also reported that administration 15 mg estradiol in this model was capable of raising estradiol to 9 times the normal level.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>13593</offset><text>At 8-18 weeks post-implantation, euthanasia was performed (CO2 inhalation) and femurs were harvested from 13 control and 33 estradiol-treated mice. Cross-sections of the femur and sections of femoral metaphyses and epiphyses were studied. For light microscopy, specimens were either fixed in 10% neutral buffered formalin, decalcified and embedded in paraffin or processed non-decalcified and embedded in methyl methacrylate. For ultrastructural studies, specimens were fixed in Karnovsky's fixative, post-fixed in osmium tetroxide, decalcified, and embedded in Spurr resin. Thin sections were prepared and grids were stained with uranyl acetate and lead citrate. Sections were viewed on a Phillips CM10 transmission electron microscope. Light microscopic sections were evaluated with quantitative histomorphometry using OsteoMeasure software (OsteoMetrics, Inc., Decatur, GA). Tartrate-resistant acid phosphatase (TRAP) localization was performed to identify osteoclasts with light microscopy. Protocols were approved by the appropriate Institutional Animal Care and Use Committee.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>14676</offset><text>Statistical analysis of quantitative histomorphometric data used standard statistical methods; means and standard deviations were calculated. Unpaired t-tests were used to test for differences between means; a p-value of &lt;0.05 was considered statistically significant.</text></passage><passage><infon key="fpage">1504</infon><infon key="lpage">1508</infon><infon key="name_0">surname:Teitelbaum;given-names:SL</infon><infon key="pub-id_doi">10.1126/science.289.5484.1504</infon><infon key="pub-id_pmid">10968780</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">289</infon><infon key="year">2000</infon><offset>14945</offset><text>Bone resorption by osteoclasts.</text></passage><passage><infon key="fpage">240</infon><infon key="lpage">250</infon><infon key="name_0">surname:Liu;given-names:C-C</infon><infon key="name_1">surname:Howard;given-names:GA</infon><infon key="pub-id_pmid">2012311</infon><infon key="section_type">REF</infon><infon key="source">Anat Rec</infon><infon key="type">ref</infon><infon key="volume">229</infon><infon key="year">1991</infon><offset>14977</offset><text>Bone-cell changes in estrogen-induced bone-mass increase in mice: Dissociation of osteoclasts from bone surfaces.</text></passage><passage><infon key="fpage">742</infon><infon key="lpage">752</infon><infon key="name_0">surname:Pederson;given-names:L</infon><infon key="name_1">surname:Kremer;given-names:M</infon><infon key="name_2">surname:Foged;given-names:NT</infon><infon key="name_3">surname:Winding;given-names:B</infon><infon key="name_4">surname:Ritchie;given-names:C</infon><infon key="name_5">surname:Fitzpatrick;given-names:LA</infon><infon key="name_6">surname:Oursler;given-names:MJ</infon><infon key="section_type">REF</infon><infon key="source"> J Bone Mineral Res</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">1997</infon><offset>15091</offset><text>Evidence of a correlation of estrogen receptor level and avian osteoclast estrogen responsiveness.</text></passage><passage><infon key="fpage">84</infon><infon key="lpage">87</infon><infon key="name_0">surname:Eriksen;given-names:E</infon><infon key="name_1">surname:Colvard;given-names:D</infon><infon key="name_2">surname:Berg;given-names:N</infon><infon key="name_3">surname:Graham;given-names:M</infon><infon key="name_4">surname:Mann;given-names:K</infon><infon key="name_5">surname:Spelsberg;given-names:TC</infon><infon key="name_6">surname:Riggs;given-names:BL</infon><infon key="pub-id_pmid">3388021</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">241</infon><infon key="year">1988</infon><offset>15190</offset><text>Evidence of estrogen receptors in normal human osteoblast-like cells.</text></passage><passage><infon key="fpage">81</infon><infon key="lpage">84</infon><infon key="name_0">surname:Komm;given-names:BS</infon><infon key="name_1">surname:Terpening;given-names:C</infon><infon key="name_2">surname:Benz;given-names:D</infon><infon key="name_3">surname:Graeme;given-names:K</infon><infon key="name_4">surname:Gallegos;given-names:A</infon><infon key="name_5">surname:Kore;given-names:M</infon><infon key="pub-id_pmid">3164526</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">241</infon><infon key="year">1988</infon><offset>15260</offset><text>Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells.</text></passage><passage><infon key="fpage">6613</infon><infon key="lpage">6617</infon><infon key="name_0">surname:Oursler;given-names:MJ</infon><infon key="name_1">surname:Osdoby;given-names:P</infon><infon key="name_2">surname:Pyfferoen;given-names:J</infon><infon key="name_3">surname:Riggs;given-names:BL</infon><infon key="pub-id_pmid">1907373</infon><infon key="section_type">REF</infon><infon key="source">Proc Natl Acad Sci USA</infon><infon key="type">ref</infon><infon key="volume">88</infon><infon key="year">1991</infon><offset>15354</offset><text>Avian osteoclasts as estrogen target cells.</text></passage><passage><infon key="fpage">4282</infon><infon key="lpage">4285</infon><infon key="name_0">surname:Puzanov;given-names:IJ</infon><infon key="name_1">surname:Bennett;given-names:M</infon><infon key="name_2">surname:Kumar;given-names:V</infon><infon key="pub-id_pmid">8906800</infon><infon key="section_type">REF</infon><infon key="source">The Journal of Immunology</infon><infon key="type">ref</infon><infon key="volume">157</infon><infon key="year">1996</infon><offset>15398</offset><text>Il-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells.</text></passage><passage><infon key="fpage">215</infon><infon key="lpage">231</infon><infon key="name_0">surname:Miller;given-names:SC</infon><infon key="name_1">surname:Jee;given-names:WSS</infon><infon key="section_type">REF</infon><infon key="source">Calcified Tissue Res</infon><infon key="type">ref</infon><infon key="volume">18</infon><infon key="year">1975</infon><offset>15499</offset><text>Ethane-1-hydroxy-1,1-diphosphonate (EHDP) effects on growth and modeling of the rat tibia.</text></passage><passage><infon key="fpage">247</infon><infon key="lpage">256</infon><infon key="name_0">surname:Plasmans;given-names:CMT</infon><infon key="name_1">surname:Jap;given-names:PHK</infon><infon key="name_2">surname:Kuijpers;given-names:W</infon><infon key="name_3">surname:Slooff;given-names:TJHH</infon><infon key="section_type">REF</infon><infon key="source">Calcified Tissue Int</infon><infon key="type">ref</infon><infon key="volume">32</infon><infon key="year">1980</infon><offset>15590</offset><text>Influence of a diphosphonate on the cellular aspect of young bone tissue.</text></passage><passage><infon key="fpage">439</infon><infon key="lpage">462</infon><infon key="name_0">surname:Miller;given-names:SC</infon><infon key="name_1">surname:Jee;given-names:WSS</infon><infon key="section_type">REF</infon><infon key="source">Anat Res</infon><infon key="type">ref</infon><infon key="volume">193</infon><infon key="year">1979</infon><offset>15664</offset><text>The effect of dichloromethylene diphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing rat.</text></passage><passage><infon key="fpage">75</infon><infon key="lpage">87</infon><infon key="name_0">surname:Lucht;given-names:U</infon><infon key="pub-id_pmid">4360462</infon><infon key="section_type">REF</infon><infon key="source">Z Zellforsch</infon><infon key="type">ref</infon><infon key="volume">145</infon><infon key="year">1973</infon><offset>15787</offset><text>Effects of calcitonin on osteoclasts in vivo.</text></passage><passage><infon key="fpage">205</infon><infon key="lpage">216</infon><infon key="name_0">surname:Kallio;given-names:DM</infon><infon key="name_1">surname:Garant;given-names:PR</infon><infon key="name_2">surname:Minkin;given-names:C</infon><infon key="section_type">REF</infon><infon key="source">J Ultrastructural Res</infon><infon key="type">ref</infon><infon key="volume">39</infon><infon key="year">1972</infon><offset>15833</offset><text>Ultrastructural effects of calcitonin on osteoclasts in tissue culture.</text></passage><passage><infon key="fpage">422</infon><infon key="lpage">433</infon><infon key="name_0">surname:Accardo;given-names:G</infon><infon key="name_1">surname:Aleotti;given-names:A</infon><infon key="name_2">surname:Ricci;given-names:D</infon><infon key="name_3">surname:Pazzi;given-names:A</infon><infon key="section_type">REF</infon><infon key="source">Curr Therapeutic Res</infon><infon key="type">ref</infon><infon key="volume">31</infon><infon key="year">1982</infon><offset>15905</offset><text>Support for the clinical use of calcitonin: Electron microscope study of the functional state of bone cells of rats after chronic treatment with calcitonin.</text></passage><passage><infon key="fpage">249</infon><infon key="lpage">257</infon><infon key="name_0">surname:Minkin;given-names:C</infon><infon key="section_type">REF</infon><infon key="source">Calcified Tissue Res</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">1973</infon><offset>16062</offset><text>Inhibition of parathyroid hormone stimulated bone resorption in vitro by the antibiotic mithramycin.</text></passage><passage><infon key="fpage">127</infon><infon key="lpage">134</infon><infon key="name_0">surname:Gruber;given-names:HE</infon><infon key="name_1">surname:Norton;given-names:HJ</infon><infon key="name_2">surname:Singer;given-names:FR</infon><infon key="pub-id_doi">10.1159/000057436</infon><infon key="pub-id_pmid">10436397</infon><infon key="section_type">REF</infon><infon key="source">Mineral and Electrolyte Metabolism</infon><infon key="type">ref</infon><infon key="volume">25</infon><infon key="year">1999</infon><offset>16163</offset><text>In vivo morphologic changes in the rat osteoclast induced by gallium nitrate: The result of toxicity or other effects?</text></passage><passage><infon key="fpage">308</infon><infon key="lpage">332</infon><infon key="name_0">surname:Roodman;given-names:GD</infon><infon key="pub-id_pmid">8854048</infon><infon key="section_type">REF</infon><infon key="source">Endocr Rev</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">1996</infon><offset>16282</offset><text>Advances in bone biology: The osteoclast.</text></passage><passage><infon key="fpage">2729</infon><infon key="lpage">2732</infon><infon key="name_0">surname:V&#228;&#228;n&#228;en;given-names:HK</infon><infon key="name_1">surname:Horton;given-names:M</infon><infon key="pub-id_pmid">7593313</infon><infon key="section_type">REF</infon><infon key="source">J Cell Science</infon><infon key="type">ref</infon><infon key="volume">108</infon><infon key="year">1995</infon><offset>16324</offset><text>The osteoclast clear zone is a specialized cell-extracellular matrix adhesion structure.</text></passage><passage><infon key="fpage">C1</infon><infon key="lpage">C7</infon><infon key="name_0">surname:Teti;given-names:A</infon><infon key="name_1">surname:Marchisio;given-names:PC</infon><infon key="name_2">surname:Zallone;given-names:AZ</infon><infon key="pub-id_pmid">1858848</infon><infon key="section_type">REF</infon><infon key="source">Amer J Physiol</infon><infon key="type">ref</infon><infon key="volume">261</infon><infon key="year">1991</infon><offset>16413</offset><text>Clear zone in osteoclast function: role of podosomes in regulation of bone-resorbing activity.</text></passage><passage><infon key="fpage">1805</infon><infon key="lpage">1813</infon><infon key="name_0">surname:Udagawa;given-names:N</infon><infon key="name_1">surname:Takahashi;given-names:N</infon><infon key="name_2">surname:Akatsu;given-names:T</infon><infon key="name_3">surname:Sasaki;given-names:T</infon><infon key="name_4">surname:Yamaguchi;given-names:A</infon><infon key="name_5">surname:Kodama;given-names:H</infon><infon key="name_6">surname:Martin;given-names:TJ</infon><infon key="name_7">surname:Suda;given-names:T</infon><infon key="pub-id_pmid">2676473</infon><infon key="section_type">REF</infon><infon key="source">Endocrinology</infon><infon key="type">ref</infon><infon key="volume">125</infon><infon key="year">1989</infon><offset>16508</offset><text>The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells.</text></passage><passage><infon key="fpage">2600</infon><infon key="lpage">2602</infon><infon key="name_0">surname:Takahashi;given-names:N</infon><infon key="name_1">surname:Akatsu;given-names:T</infon><infon key="name_2">surname:Udagawa;given-names:N</infon><infon key="name_3">surname:Sasaki;given-names:T</infon><infon key="name_4">surname:Yamaguchi;given-names:A</infon><infon key="name_5">surname:Moseley;given-names:JM</infon><infon key="name_6">surname:Martin;given-names:TJ</infon><infon key="name_7">surname:Suda;given-names:T</infon><infon key="pub-id_pmid">2844518</infon><infon key="section_type">REF</infon><infon key="source">Endocrinology</infon><infon key="type">ref</infon><infon key="volume">123</infon><infon key="year">1988</infon><offset>16656</offset><text>Osteoblastic cells are involved in osteoclast formation.</text></passage><passage><infon key="fpage">338</infon><infon key="lpage">338</infon><infon key="name_0">surname:Baylink;given-names:DJ</infon><infon key="name_1">surname:Farley;given-names:J</infon><infon key="name_2">surname:Donahue;given-names:L</infon><infon key="name_3">surname:Rosen;given-names:CJ</infon><infon key="name_4">surname:Barr;given-names:B</infon><infon key="name_5">surname:Lee;given-names:J</infon><infon key="name_6">surname:Beamer;given-names:W</infon><infon key="section_type">REF</infon><infon key="source">J Bone Mineral Res</infon><infon key="type">ref</infon><infon key="volume">10 (Suppl.)</infon><infon key="year">1995</infon><offset>16713</offset><text>Evidence that high peak bone density is due to decreased resorption not increased formation in a murine model.</text></passage><passage><infon key="fpage">39</infon><infon key="lpage">46</infon><infon key="name_0">surname:Linkhart;given-names:TA</infon><infon key="name_1">surname:Linkhart;given-names:SG</infon><infon key="name_10">surname:Rosen;given-names:CJ</infon><infon key="name_11">surname:Baylink;given-names:DJ</infon><infon key="name_2">surname:Kodama;given-names:Y</infon><infon key="name_3">surname:Farley;given-names:JR</infon><infon key="name_4">surname:Dimai;given-names:HP</infon><infon key="name_5">surname:Wright;given-names:KR</infon><infon key="name_6">surname:Wergedal;given-names:JE</infon><infon key="name_7">surname:Sheng;given-names:M</infon><infon key="name_8">surname:Beamer;given-names:WG</infon><infon key="name_9">surname:Donahue;given-names:LR</infon><infon key="pub-id_pmid">9893064</infon><infon key="section_type">REF</infon><infon key="source">J Bone Miner Res</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">1999</infon><offset>16824</offset><text>Osteoclast formation in bone marrow cultures from two inbred strains of mice with different bone densities.</text></passage><passage><infon key="fpage">7260</infon><infon key="lpage">7264</infon><infon key="name_0">surname:Udagawa;given-names:N</infon><infon key="name_1">surname:Takashashi;given-names:N</infon><infon key="name_2">surname:Akatsu;given-names:T</infon><infon key="name_3">surname:Tanaka;given-names:H</infon><infon key="name_4">surname:Sasaki;given-names:T</infon><infon key="name_5">surname:Nishihara;given-names:T</infon><infon key="name_6">surname:Koga;given-names:T</infon><infon key="name_7">surname:Martin;given-names:TJ</infon><infon key="name_8">surname:Suda;given-names:T</infon><infon key="pub-id_pmid">2169622</infon><infon key="section_type">REF</infon><infon key="source">Proc Natl Acad Sci  USA</infon><infon key="type">ref</infon><infon key="volume">87</infon><infon key="year">1990</infon><offset>16932</offset><text>Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells.</text></passage><passage><infon key="fpage">4382</infon><infon key="lpage">4389</infon><infon key="name_0">surname:Hofbauer;given-names:L.C.</infon><infon key="name_1">surname:Gori;given-names:F</infon><infon key="name_2">surname:Riggs;given-names:BL</infon><infon key="name_3">surname:Lacey;given-names:DL</infon><infon key="name_4">surname:Dunstan;given-names:CR</infon><infon key="name_5">surname:Spelsberg;given-names:TC</infon><infon key="name_6">surname:Khosla;given-names:S</infon><infon key="pub-id_pmid">10499489</infon><infon key="section_type">REF</infon><infon key="source">Endocrinology</infon><infon key="type">ref</infon><infon key="volume">140</infon><infon key="year">1999</infon><offset>17117</offset><text>Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis.</text></passage><passage><infon key="fpage">4367</infon><infon key="lpage">4370</infon><infon key="name_0">surname:Hofbauer;given-names:L.C.</infon><infon key="name_1">surname:Khosla;given-names:S.</infon><infon key="name_2">surname:Dunstan;given-names:D.R.</infon><infon key="name_3">surname:Lacey;given-names:D.L.</infon><infon key="name_4">surname:Spelsbert;given-names:T.C.</infon><infon key="name_5">surname:Riggs;given-names:B.L</infon><infon key="pub-id_pmid">10465311</infon><infon key="section_type">REF</infon><infon key="source">Endocrinology</infon><infon key="type">ref</infon><infon key="volume">140</infon><infon key="year">1999</infon><offset>17327</offset><text>Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells.</text></passage><passage><infon key="fpage">1409</infon><infon key="lpage">1418</infon><infon key="name_0">surname:Sunyer;given-names:T</infon><infon key="name_1">surname:Lewis;given-names:J</infon><infon key="name_2">surname:Collin-Osdoby;given-names:P</infon><infon key="name_3">surname:Osdoby;given-names:P</infon><infon key="pub-id_pmid">10330423</infon><infon key="section_type">REF</infon><infon key="source">J Clin Invest</infon><infon key="type">ref</infon><infon key="volume">103</infon><infon key="year">1999</infon><offset>17434</offset><text>Estrogen's bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells.</text></passage><passage><infon key="fpage">1861</infon><infon key="lpage">1866</infon><infon key="name_0">surname:Brubaker;given-names:KD</infon><infon key="name_1">surname:Gay;given-names:CV</infon><infon key="pub-id_pmid">10571686</infon><infon key="section_type">REF</infon><infon key="source">J Bone Miner Res</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">1999</infon><offset>17551</offset><text>Depolarization of osteoclast plasma membrane potential by 17b-estradiol.</text></passage><passage><infon key="fpage">1251</infon><infon key="lpage">1259</infon><infon key="name_0">surname:Gay;given-names:CV</infon><infon key="name_1">surname:Kief;given-names:NL</infon><infon key="name_2">surname:Bekker;given-names:PJ</infon><infon key="pub-id_doi">10.1006/bbrc.1993.1551</infon><infon key="pub-id_pmid">8389545</infon><infon key="section_type">REF</infon><infon key="source">Biochem Biophys Res Commun</infon><infon key="type">ref</infon><infon key="volume">192</infon><infon key="year">1993</infon><offset>17624</offset><text>Effect of estrogen on acidification in osteoclasts.</text></passage><passage><infon key="fpage">233</infon><infon key="lpage">240</infon><infon key="name_0">surname:Fiorelli;given-names:G</infon><infon key="name_1">surname:Gori;given-names:F</infon><infon key="name_2">surname:Frediani;given-names:U</infon><infon key="name_3">surname:Franceschelli;given-names:FTA</infon><infon key="name_4">surname:Tosti-Guerra;given-names:C</infon><infon key="name_5">surname:Benvenuti;given-names:S</infon><infon key="name_6">surname:Gennari;given-names:L</infon><infon key="name_7">surname:Becherini;given-names:L</infon><infon key="name_8">surname:Brandi;given-names:ML</infon><infon key="pub-id_doi">10.1016/S0960-0760(96)00092-1</infon><infon key="pub-id_pmid">9010339</infon><infon key="section_type">REF</infon><infon key="source">J Steroid Biochem Mol Biol</infon><infon key="type">ref</infon><infon key="volume">59</infon><infon key="year">1996</infon><offset>17676</offset><text>Membrane binding sites and non-genomic effects of estrogen in cultured human pre-osteoclastic cells.</text></passage><passage><infon key="fpage">88</infon><infon key="lpage">91</infon><infon key="name_0">surname:Jilka;given-names:RL</infon><infon key="name_1">surname:Hangoc;given-names:G</infon><infon key="name_2">surname:Firasole;given-names:G</infon><infon key="name_3">surname:Passeri;given-names:G</infon><infon key="name_4">surname:Williams;given-names:DC</infon><infon key="name_5">surname:Abrams;given-names:JS</infon><infon key="name_6">surname:Boyce;given-names:B</infon><infon key="name_7">surname:Broxmeyer;given-names:H</infon><infon key="name_8">surname:Manolagas;given-names:SC</infon><infon key="pub-id_pmid">1621100</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">257</infon><infon key="year">1992</infon><offset>17777</offset><text>Increased osteoclast development after estrogen loss: mediation by interleukin-6.</text></passage><passage><infon key="fpage">883</infon><infon key="lpage">891</infon><infon key="name_0">surname:Girasole;given-names:G</infon><infon key="name_1">surname:Jilka;given-names:RL</infon><infon key="name_2">surname:Passeri;given-names:G</infon><infon key="name_3">surname:Boswell;given-names:S</infon><infon key="name_4">surname:Boder;given-names:G</infon><infon key="name_5">surname:Williams;given-names:DC</infon><infon key="name_6">surname:Manolagas;given-names:SC</infon><infon key="pub-id_pmid">1541679</infon><infon key="section_type">REF</infon><infon key="source">J Clin Invest</infon><infon key="type">ref</infon><infon key="volume">89</infon><infon key="year">1992</infon><offset>17859</offset><text>17b-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens.</text></passage><passage><infon key="fpage">3124</infon><infon key="lpage">3131</infon><infon key="name_0">surname:Hackett;given-names:T;suffix:Jr.</infon><infon key="name_1">surname:Tutt;given-names:M</infon><infon key="name_2">surname:Lipscomb;given-names:M</infon><infon key="name_3">surname:Bennett;given-names:M</infon><infon key="name_4">surname:Koo;given-names:G</infon><infon key="name_5">surname:Kumar;given-names:V</infon><infon key="pub-id_pmid">3958492</infon><infon key="section_type">REF</infon><infon key="source">J Immunology</infon><infon key="type">ref</infon><infon key="volume">136</infon><infon key="year">1986</infon><offset>18038</offset><text>Origin and differentiation of natural killer cells. II. Functional and morphologic studies of purified NK-1.1+ cells.</text></passage><passage><infon key="fpage">71</infon><infon key="lpage">87</infon><infon key="name_0">surname:Bennett;given-names:M</infon><infon key="name_1">surname:Baker;given-names:EE</infon><infon key="name_2">surname:Eastcott;given-names:JW</infon><infon key="name_3">surname:Kumar;given-names:V</infon><infon key="name_4">surname:Yonkosky;given-names:D</infon><infon key="section_type">REF</infon><infon key="source">J of the Reticuloendothelial Society</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="year">1976</infon><offset>18156</offset><text>Selective elimination of marrow precursors with the bone-seeking isotope 89Sr: implications for hemopoiesis, lymphopoiesis, viral leukemogenesis and infection.</text></passage><passage><infon key="fpage">2541</infon><infon key="lpage">2547</infon><infon key="name_0">surname:Seaman;given-names:WE</infon><infon key="name_1">surname:Gindhart;given-names:TD</infon><infon key="name_2">surname:Greenspan;given-names:JS</infon><infon key="name_3">surname:Blackman;given-names:MA</infon><infon key="name_4">surname:Talal;given-names:N</infon><infon key="pub-id_pmid">376736</infon><infon key="section_type">REF</infon><infon key="source">J Immunology</infon><infon key="type">ref</infon><infon key="volume">122</infon><infon key="year">1979</infon><offset>18316</offset><text>Natural killer cell, bone, and the bone marrow: studies in estrogen-treated mice and in congenitally osteopetrotic (mi/mi) mice.</text></passage><passage><infon key="fpage">1832</infon><infon key="lpage">1838</infon><infon key="name_0">surname:Kumar;given-names:V.</infon><infon key="name_1">surname:Ben-Ezra;given-names:J</infon><infon key="name_2">surname:Bennett;given-names:M</infon><infon key="name_3">surname:Sonnenfeld;given-names:G</infon><infon key="pub-id_pmid">383842</infon><infon key="section_type">REF</infon><infon key="source">J Immunology</infon><infon key="type">ref</infon><infon key="volume">123</infon><infon key="year">1979</infon><offset>18445</offset><text>Natural killer cells in mice treated with 89strontium: normal target-binding cell numbers but inability to kill even after interferon administration.</text></passage><passage><infon key="fpage">1568</infon><infon key="lpage">1583</infon><infon key="name_0">surname:Roubinian;given-names:JR</infon><infon key="name_1">surname:Talal;given-names:N</infon><infon key="name_2">surname:Greenspan;given-names:JS</infon><infon key="name_3">surname:Goodman;given-names:JR</infon><infon key="name_4">surname:Siiteri;given-names:PK</infon><infon key="pub-id_pmid">308087</infon><infon key="section_type">REF</infon><infon key="source">J Exp Med</infon><infon key="type">ref</infon><infon key="volume">147</infon><infon key="year">1978</infon><offset>18595</offset><text>Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW mice.</text></passage><passage><infon key="fpage">2541</infon><infon key="lpage">2547</infon><infon key="name_0">surname:Seaman;given-names:WE</infon><infon key="name_1">surname:Gindhart;given-names:TD</infon><infon key="name_2">surname:Greenspan;given-names:JS</infon><infon key="name_3">surname:Blackman;given-names:MA</infon><infon key="name_4">surname:Talal;given-names:N</infon><infon key="pub-id_pmid">376736</infon><infon key="section_type">REF</infon><infon key="source">J Immunol</infon><infon key="type">ref</infon><infon key="volume">122</infon><offset>18725</offset><text>Natural killer cells, bone, and the bone marrow: Studies in estrogen-treated mice and in congenitally osteopetrotic (mi/mi) mice.</text></passage><passage><infon key="fpage">1234</infon><infon key="lpage">1240</infon><infon key="name_0">surname:Seaman;given-names:WE</infon><infon key="name_1">surname:Gindhart;given-names:TD</infon><infon key="pub-id_pmid">389248</infon><infon key="section_type">REF</infon><infon key="source">Arthritis and Rheumatism</infon><infon key="type">ref</infon><infon key="volume">22</infon><infon key="year">1979</infon><offset>18855</offset><text>Effect of estrogen on natural killer cells.</text></passage></document></collection>